Global Angiography Devices Market Overview:
The Angiography devices are one type of medical imaging technique that used in visualize blood vessels in the brain, neck, heart, and kidneys. The Angiography devices used to detect the abnormalities and blood vessels blockage throughout the circulatory systems. Major driving factors for the increase of angiography devices are rise in Interventional Angiography Systems in Minimally Invasive Surgeries and government funding activities. This factor is expected to boost the global market. The major companies are adding more proven technologies systematically and strategically in Asia-Pacific countries as these countries are focused on better health facilities. According to AMA, the Global Angiography Devices market is expected to see growth rate of 5.2% and may see market size of USD13570.0 Million by 2024.
- Upsurge Investment in Healthcare Sector.
- Increase in Prevalence of Cardio-Vascular Diseases.
- Upsurge demand of innovative technology such as MRA & CT and digital flat panel detectors devices
- High Cost Associated With Angiography Devices.
- Regulation Upgradation Hampers the Angiography Devices Market.
- Rise in Aging Population Leads to Boost the Angiography Devices Market.
- Technological Developments in Healthcare Sectors Lead to Grow the Angiography Devices Market.
- It can only be Applicable in Active Bleeding.
Some of the key players profiled in the report are GE Healthcare (United States), Siemens Healthcare (Germany), Toshiba Corporation (Japan), Medtronic Inc. (Ireland), ST. Jude Medical (United States), Abbott Vascular (United States), Boston Scientific Corporation (United States), Cordis Corporation (United States), Philips Healthcare (Netherlands) and Shimadzu Corporation (Japan). Analyst at AdvanceMarketAnalytics see United States Players to retain maximum share of Global Angiography Devices market by 2024. Considering Market by Indication, the sub-segment i.e. Known Suspected CAD will boost the Angiography Devices market. Considering Market by Procedure, the sub-segment i.e. Coronary Angiography will boost the Angiography Devices market. Considering Market by End-Users , the sub-segment i.e. Hospitals will boost the Angiography Devices market.
In February 2018, Philips launched a Azurion angiography system which is beneficial in providing several imaging and software enhancements to aid guidance during complex interventional procedures. It also delivered smart-touch display attached to the table-side controls, that target for vascular and interventional radiology applications.
“According to U.S. Food and Drugs Administration , it’s denoted that the Angiographic injector and syringe should be in a convenient kits as listed in the guidance note, is under enforcement discretion, and does not require a premarket notification (510(k)) to market if it meets all criteria in the guidance.”
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be provided prior to purchase
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Angiography Devices market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Angiography Devices market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Angiography Devices Manufacturers, Angiography Devices Traders, End-Use Market Participants of Different Segments of Angiography Devices, Government and Research Organizations, Associations and Industrial Bodies, Research and Consulting Firms, R&D Institutions and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.